Drug patents revoked in 2019
Drug patents revoked in 2019 at the European Patent Office (EPO)
| Patent Number | Patent Title | Company | Revoked Date | Oppositions |
|---|---|---|---|---|
| EP1956014B1 | Polymorphs Of 2-(3-Cyano-4-Isobutyloxyphenyl)-4-Methyl-5-Thiazolecarboxylic Acid And Method Of Producing The Same | TEIJIN PHARMA LTD |
Dec, 2019
|
DR SCHN
|
| EP2874647B1 | Method Of Diagnosis And Treatment | LA TROBE UNIVERSITY |
Dec, 2019
|
GRUND
|
| EP2574166B1 | Cosmetics Comprising Cosmetic Composition-Impregnated Urethane Foam | AMOREPACIFIC CORP |
Dec, 2019
|
COSMAX
|
| EP2025318B1 | Two-Phase Composition For Conditioning Hair | KAO GERMANY GMBH |
Dec, 2019
|
HENKEL
|
| EP2882454B1 | Combination Therapy For The Treatment Of Glioblastoma | F HOFFMANN LA ROCHE AG |
Dec, 2019
|
DRRIES
NEUEFEIND
PFIZER
|
| EP3046590B1 | Method For Producing A Liquid Pharmaceutical Preparation | SANOCHEMIA PHARMAZEUTIKA AG |
Dec, 2019
|
GUERBET
|
| EP3214091B1 | Use Of Chimeric Antigen Receptor-Modified T Cells To Treat Cancer | UNIVERSITY OF PENNSYLVANIA PENN |
Dec, 2019
|
CABINET PLASSERAUD
MDECINS DU MONDE ET AL
MILTENYI BIOTEC
PUBLIC EYE
|
| EP3094331B1 | Combination-Based Treatment Method | NEKTAR THERAPEUTICS |
Dec, 2019
|
IPSEN BIOPHARM
|
| EP2759294B1 | Percutaneously Absorbable Preparation Containing Fentanyl And A Homologue Thereof | SAMYANG BIOPHARMACEUTICALS CORP |
Dec, 2019
|
HEXAL
|
| EP2852371B1 | Cosmetic Compositions Comprising Magnetosomes And Uses Thereof | NATURA BISSE INTERNATIONAL SA |
Dec, 2019
|
WITTOP KONING
|
| EP2554168B1 | Controlled Release Pharmaceutical Composition | ASTELLAS PHARMA INC |
Dec, 2019
|
ALFRED E TIEFENBACHER
HEXAL
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
STADA ARZNEIMITTEL
|
| EP1848422B1 | Method For Decreasing Cartilage Damage In Dogs | HILLS PET NUTRITION INC |
Dec, 2019
|
IAMS EUROPE
MARS
|
| EP2051694B1 | Pharmaceutical Compositions Comprising Aripiprazole | NOBEL ILAC SANAYII VE TICARET AS |
Dec, 2019
|
MULLEN
|
| EP2216028B1 | Immunostimulation By Chemically Modified Rna | CUREVAC AG |
Dec, 2019
|
ETHERNA IMMUNOTHERAPIES
SCHNAPPAUF
STRAWMAN
|
| EP2994125B1 | Efficacious Treatment Of Nsclc And Predictive Clinical Marker Of The Responsiveness Of A Tumour To A Treatment | BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
Dec, 2019
|
DEXCEL PHARMA
GENERICS UK
HGF
TEVA PHARMACEUTICAL INDUSTRIES
|
| EP2608784B1 | Treatment Of Hypertension And/Or Prevention Or Treatment Of Heart Failure In A Mammal Receiving Anti-Coagulant Therapy | NOVARTIS AG |
Dec, 2019
|
ALFRED E TIEFENBACHER
GENERICS UK
ZENTIVA
|
| EP1711162B1 | Method For The Diffusion Of Molecules Which Are Insoluble In An Aqueous Medium And Composition Using Said Method | INDIVIDUAL |
Nov, 2019
|
SANOFI
|
| EP2311492B1 | Antibody-Containing Stabilized Preparations | CHUGAI PHARMACEUTICAL CO LTD |
Nov, 2019
|
MATHYS & SQUIRE
|
| EP2645878B1 | Prevention Or Treatment Of Overweight And Obesity In Type 2 Diabetic Patients | NUTRICIA NV |
Nov, 2019
|
FRESENIUS KABI DEUTSCHLAND
|
| EP3019146B1 | Long-Wear Cosmetic Composition | LOREAL SA |
Nov, 2019
|
HENKEL
|
| EP2758027B1 | Perfume | COTY INC |
Nov, 2019
|
HENKEL
|
| EP2682388B1 | Novel Polymorphic Forms Of Perindopril (L)-Arginine And Process For The Preparation Thereof | MYLAN LABORATORIES LTD |
Nov, 2019
|
HOEFER & PARTNER PATENTANWLTE MBB
LES LABORATOIRES SERVIER
|
| EP2694043B1 | Combinations Comprising Brexpiprazole Or A Salt Thereof And A Second Drug For Use In The Treatment Of A Cns Disorder | OTSUKA PHARMACEUTICAL CO LTD |
Nov, 2019
|
ALFRED E TIEFENBACHER
GENERICS UK
|
| EP2839826B1 | Octocrylene-Free Sunscreen | BEIERSDORF AG |
Nov, 2019
|
BAYER BAYER CONSUMER CARE
LOREAL
|
| EP2964675B1 | Engager Cells For Immunotherapy | BAYLOR COLLEGE OF MEDICINE |
Nov, 2019
|
SCHLICH
|
| EP2269603B1 | Treatment Of Solid Tumours With Rapamycin Derivatives | NOVARTIS PHARMA GMBH |
Oct, 2019
|
ACTAVIS PTC EHF
ETHYPHARM
GENERICS UK
INTAS PHARMACEUTICALS
STADA ARZNEIMITTEL
SYNTHON
TEVA PHARMACEUTICALS
WITTKOPP
ZENTIVA FRANCE
|
| EP2661492B1 | Method Of Production Of Recombinant Glycoproteins With Increased Circulatory Half-Life In Mammalian Cells | JOHNS HOPKINS UNIVERSITY |
Oct, 2019
|
I P S SERVICES
|
| EP3021820B1 | Antiperspirant Spray Devices And Compositions | PROCTER AND GAMBLE CO |
Oct, 2019
|
BEIERSDORF
|
| EP2899193B1 | Crystalline Form Of Abacavir That Is Essentially Free Of Solvent | ESTEVE QUIMICA SA |
Oct, 2019
|
D YOUNG
FRKELLY
HAMM&WITTKOPP PATENTANWLTE PARTMBB
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
TER MEER STEINMEISTER & PARTNER PATENTANWLTE MBB
|
| EP1955602B1 | Milk Fractions And Milk Preparations For Treating And/Or Preventing Cox-2 Mediated Diseases | NESTEC SA |
Oct, 2019
|
ABBOTT LABORATORIES
|
| EP2307058B1 | Glycerophospholipids For The Improvement Of Cognitive Functions | ENZYMOTEC LTD |
Oct, 2019
|
NUTRICIA
|
| EP3016630B1 | Cosmetic Composition Comprising Liquid Fatty Esters, Volatile Oils And Thickeners, And Cosmetic Treatment Processes | LOREAL SA |
Oct, 2019
|
HENKEL
|
| EP2869706B1 | Method For Producing A Protein Comprising Composition With Reduced Digestive Coagulation | NUTRICIA NV |
Oct, 2019
|
NESTEC
|
| EP2560662B1 | Sulodexide For Use In The Treatment Of Pathologies Wherein Metalloproteinases Are Involved | ALFA WASSERMAN SPA |
Oct, 2019
|
BOTTI & FERRARI
GENERICS UK
|
| EP2866777B1 | Reducing Composition Comprising At Least One Sulfur-Containing Reducing Agent, At Least One Fatty Substance, At Least One Cationic Surfactant And At Least One Oxyethylenated Nonionic Surfactant | LOREAL SA |
Oct, 2019
|
HENKEL
|
| EP2429507B1 | Phosphate-Free Pharmaceutical Composition For The Treatment Of Glaucoma | URSAPHARM ARZNEIMITTEL GMBH |
Oct, 2019
|
PHARMA STULLN
|
| EP2701689B1 | Pharmaceutical Compositions Of Raltegravir, Methods Of Preparation And Use Thereof | HETERO RESEARCH FOUNDATION |
Oct, 2019
|
GILL JENNINGS & EVERY
TER MEER STEINMEISTER & PARTNER PATENTANWLTE MBB
|
| EP2943081B1 | Nutritional Compositions Containing Magnesium Threonate And Uses Thereof | MJN US HOLDINGS LLC |
Oct, 2019
|
NESTEC
|
| EP1800659B1 | Cosmetic Composition Comprising At Least One Cationic Polyvinyllactam, At Least One Fatty Alcohol And At Least One Polyol, Method For Treatment Of Keratin Fibres And Use | LOREAL SA |
Oct, 2019
|
KAO GERMANY
|
| EP2234584B1 | Composition Comprising An Alkanolamine, A Basic Amino Acid And A Suitably Selected Additional Alkaline Agent | LOREAL SA |
Sep, 2019
|
HENKEL
|
| EP2376052B1 | Inorganic Gel And Composition And Process For The Production Thereof | BEIERSDORF AG |
Sep, 2019
|
THE PROCTER & GAMBLE
|
| EP1710259B1 | Cosmetic Composition Thickened With An Inverse Latex | SOCIETE DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC SA |
Sep, 2019
|
SNF
|
| EP2802646B1 | Modified Bordetella Pertussis Strains | BIONET-ASIA CO LTD |
Sep, 2019
|
GLAXO SMITHKLINE BIOLOGICALS
|
| EP2805716B1 | A Pharmaceutical Composition Having A Rapid Action | OREXO AB |
Sep, 2019
|
PATENTANWALTSKANZLEI CARTAGENA PARTNERSCHAFTSGESELLSCHAFT KLEMENT
|
| EP2266531B1 | Cosmetic Composition Comprising A Superabsorbent Polymer And An Organic Uv Filter | LOREAL SA |
Sep, 2019
|
THE PROCTER & GAMBLE
|
| EP2827830B1 | Preservative Composition And Cosmetic Products Containing Same | HENKEL AG AND CO KGAA |
Sep, 2019
|
BEIERSDORF
|
| EP2194957B1 | Composition Comprising At Least One Ammonium Salt, Aqueous Ammonia And At Least One Amino Acid | LOREAL SA |
Sep, 2019
|
HENKEL
|
| EP2736481B1 | Method Of Removing Colour From Oxidatively Dyed Hair | PERACHEM LTD |
Sep, 2019
|
HENKEL
|
| EP2560606B1 | Colouring Composition | KAO GERMANY GMBH |
Sep, 2019
|
LOREAL
|
| EP2455062B1 | Skin Cleanser/Hand Cleaners Comprising Hydrophilic Emollients And Abrasives | DEB IP LTD |
Sep, 2019
|
HENKEL
|
| EP2800567B1 | An Inhaler Comprising A Tiotropium-Containing-Composition | TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D INC |
Sep, 2019
|
M UNITED KINGDOM
|
| EP2037965B1 | Pharmaceutical Composition With Synergistic Anticonvulsant Effect | UCB PHARMA GMBH |
Sep, 2019
|
ACCORD HEALTHCARE
|
| EP2560608B1 | Colouring Composition | KAO GERMANY GMBH |
Sep, 2019
|
HENKEL
|
| EP2931741B1 | Porcine Parvovirus 5A, Methods Of Use And Vaccine | BOEHRINGER INGELHEIM VETMEDICA INC |
Sep, 2019
|
INTERVET
|
| EP2214677B1 | Compositions For The Treatment Of Inflammation Of The Gastrointestinal Tract | MERITAGE PHARMA INC |
Sep, 2019
|
DR FALK PHARMA
|
| EP2558092B1 | Combination Comprising A Cyclin Dependent Kinase 4 Or Cyclin Dependent Kinase (Cdk4/6) Inhibitor And An Mtor Inhibitor For Treating Cancer | NOVARTIS AG |
Aug, 2019
|
GENERICS UK
|
| EP1589109B1 | Vmp-Like Sequences Of Pathogenic Borrelia | UNIVERSITY OF TEXAS SYSTEM |
Jul, 2019
|
MIKROGEN
|
| EP2618833B1 | Breast Cancer Therapeutics | IMBA INSTITUT FUR MOLEKULARE BIOTECHONOLOGIE GMBH |
Jul, 2019
|
DEHMEL & BETTENHAUSEN PATENTANWLTE PARTMBB
PATENTANWLTE ISENBRUCK BSL HRSCHLER PARTG MBB
|
| EP2643322B1 | Salts And Crystalline Forms Of An Apoptosis-Inducing Agent | ABBVIE INC |
Jul, 2019
|
GENERICS UK
|
| EP2568968B1 | Manufacturing Of Active-Free Granules And Tablets Comprising The Same | EURO CELTIQUE SA |
Jul, 2019
|
HERTIN UND PARTNER RECHTS UND PATENTANWLTE PARTG MBB
|
| EP2907522B1 | Method Of Increasing Bone Toughness And Stiffness And Reducing Fractures | ELI LILLY AND CO |
Jul, 2019
|
GEDEON RICHTER RICHTER HELM BIOLOGICS RICHTER HELM BIOTEC
STADA ARZNEIMITTEL
TEVA PHARMACEUTICAL INDUSTRIES
|
| EP2119426B1 | Oral And Personal Care Compositions And Methods | COLGATE PALMOLIVE CO |
Jul, 2019
|
KAO GERMANY
|
| EP1589951B1 | Use Of A Mixture Of Two Or More Enteric Materials To Regulate Drug Release Via Membrane Or Matrix For Systemic Therapeutics | SUPERNUS PHARMACEUTICALS INC |
Jun, 2019
|
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
|
| EP2934515B1 | Pharmaceutical Combination Comprising Binimetinib | NOVARTIS AG |
Jun, 2019
|
FRESENIUS KABI DEUTSCHLAND
|
| EP2663278B1 | Cosmetic Cleaning Agent | HENKEL AG AND CO KGAA |
Jun, 2019
|
LORAL
|
| EP2699091B1 | 2',6'-Dioxo-3'-Deutero-Piperdin-3-Yl-Isoindoline Compounds | DEUTERX LLC |
Jun, 2019
|
JOHNSON
|
| EP2646470B1 | Low Affinity Blood Brain Barrier Receptor Antibodies And Uses Therefor | F HOFFMANN LA ROCHE AG |
Jun, 2019
|
EIP
PFIZER
SANOFI
|
| EP2266958B1 | Antiviral Agent | SHIONOGI AND CO LTD |
Jun, 2019
|
MERCK
|
| EP1798285B1 | Methods And Medicament For Inhibition The Expression Of A Defined Gene | ALNYLAM EUROPE AG |
Jun, 2019
|
SILENCE THERAPEUTICS
|
| EP2882498B1 | Agent And Method For The Temporary Deformation Of Keratin Fibres | HENKEL AG AND CO KGAA |
Jun, 2019
|
LOREAL
|
| EP2198831B1 | Method For Lightening, Lightening Direct Dyeing Or Oxidation Dyeing Carried Out In The Presence Of An Organic Amine And A Mineral Base; Suitable Kit | LOREAL SA |
May, 2019
|
HENKEL
|
| EP2981509B1 | High-Strength, Translucent Mg-High Quartz Mixed Crystal Glass Ceramics | SIRONA DENTAL SYSTEMS GMBH |
May, 2019
|
IVOCLAR VIVADENT
|
| EP2440232B1 | Glycomacropeptide Medical Foods For Nutritional Management Of Phenylketonuria And Other Metabolic Disorders | WISCONSIN ALUMNI RESEARCH FOUNDATION |
Apr, 2019
|
NEUEFEIND
NUTRICIA
|
| EP3045182B1 | Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide And Methods Using Same | TEVA PHARMACEUTICALS INTERNATIONAL GMBH |
Apr, 2019
|
BREUER
ELI LILLY
|
| EP2753190B1 | Use Of Infant Formula With Cholesterol | NUTRICIA NV |
Apr, 2019
|
NESTEC
|
| EP2234628B1 | Compositions And Methods Of Promoting Wound Healing | CLEVELAND CLINIC FOUNDATION |
Apr, 2019
|
DEHNS
|
| EP2665463B1 | Antiperspirant Stick With Improved Long-Term Stability | HENKEL AG AND CO KGAA |
Apr, 2019
|
THE PROCTER & GAMBLE
|
| EP2701713B1 | Modulation Of Apolipoprotein Ciii (Apociii) Expression | IONIS PHARMACEUTICALS INC |
Apr, 2019
|
PFIZER
STRAWMAN
|
| EP2934464B1 | Personal Care Compositions Comprising Anionic Surfactants And Hydrophobic Actives | DOW GLOBAL TECHNOLOGIES LLC |
Apr, 2019
|
FIRMENICH
FLAVORS & FRAGRANCES
GIVAUDAN
|
| EP2313073B1 | Non-Sulfate Mild Surfactant System For Skin And Hair Cleaning | HENKEL AG AND CO KGAA |
Apr, 2019
|
BEIERSDORF
LOREAL
THE PROCTER & GAMBLE
|
| EP2908835B1 | Stable Formulations | MONTERO GIDA SANAYI VE TICARET AS |
Apr, 2019
|
DR WILLMAR SCHWABE
|
| EP3050882B1 | Piperidin-4-Yl Azetidine Derivatives As Jak1 Inhibitors | INCYTE HOLDINGS CORP |
Apr, 2019
|
GENERICS UK
|
| EP3157932B1 | Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5]Pyrazino [2, 1-B]Oxazepin-8-Olate | GILEAD SCIENCES INC |
Mar, 2019
|
COOKE
|
| EP2496700B1 | Nucleic Acid-Containing Lipid Particles And Related Methods | UNIVERSITY OF BRITISH COLUMBIA |
Mar, 2019
|
MERCK SHARP & DOHME
WITHERS & ROGERS
|
| EP2558435B1 | Crystalline Ingenol Mebutate | LEO PHARMA AS |
Mar, 2019
|
GENERICS UK
TEVA PHARMACEUTICAL INDUSTRIES
|
| EP2198843B1 | Lightening Of Human Keratinic Fibers With A Anhydrous Composition Comprising A Mixture Of Monoethanolamine/Basic Amine Acid And Kit | LOREAL SA |
Feb, 2019
|
HENKEL
|
| EP3000810B1 | N3 Alkylated Benzimidazole Derivative As Mek Inhibitor | ARRAY BIOPHARMA INC |
Feb, 2019
|
GENERICS UK TRADING MYLAN
|
| EP2529622B1 | Inhibitors Of Bruton'S Tyrosine Kinase | PHARMACYCLICS LLC |
Feb, 2019
|
GENERICS UK
|
| EP1885203B1 | Methods For Promoting Health Or Wellness In Adult Animals | HILLS PET NUTRITION INC |
Feb, 2019
|
GEVERS PATENTS
MARS
|
| EP2249775B1 | Topical Antimicrobial Compositions | RECKITT BENCKISER LLC |
Feb, 2019
|
HENKEL
|
| EP2265248B1 | Use Of One Or More Salts Of Glycyrrhizic Acid For Reducing The Irritating Action Of Surfactants In Cosmetic Compositions | GIULIANI SPA |
Feb, 2019
|
BEIERSDORF
|
| EP2120568B1 | Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders | CELATOR PHARMACEUTICALS INC |
Feb, 2019
|
GENERICS UK
TEVA PHARMACEUTICAL INDUSTRIES
|
| EP2227215B1 | Compositions Containing A Solvated Active Agent Suitable For Dispensing As A Compressed Gas Aerosol | SC JOHNSON AND SON INC |
Feb, 2019
|
THE PROCTER & GAMBLE
|
| EP2734210B1 | Galactooligosaccharides For Preventing Injury And/Or Promoting Healing Of The Gastrointestinal Tract | ABBOTT LABORATORIES |
Jan, 2019
|
FRESENIUS KABI DEUTSCHLAND
NUTRICIA
|